Related Experiment Video
Updated: Apr 5, 2026
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
BRACAnalysis CDx as a companion diagnostic tool for Lynparza
Camille C Gunderson1, Kathleen N Moore
1a University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Division of Gynecologic Oncology, 800 NE 10th Street, Suite 5040, Oklahoma City, OK 73104, USA.
Lynparza, a PARP inhibitor, and its companion diagnostic test, BRACAnalysis, were approved for ovarian cancer in women with BRCA mutations. This diagnostic offers comprehensive germline profiling, benefiting patients and their families.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Ovarian cancer is often linked to germline BRCA mutations, impairing DNA repair.
- Deficient homologous recombination repair predisposes women to ovarian cancer.
Purpose of the Study:
- To discuss the FDA approval of Lynparza and its companion diagnostic, BRACAnalysis, for ovarian cancer treatment.
- To highlight the unique features of BRACAnalysis as a companion diagnostic.
Main Methods:
- Review of FDA approval documentation for Lynparza and BRACAnalysis.
- Analysis of the mechanisms of action for PARP inhibitors and PARP trapping.
- Comparison of BRACAnalysis with other companion diagnostics in oncology.
Main Results:
- Lynparza and BRACAnalysis approved in December 2014 for recurrent ovarian cancer in women with germline BRCA mutations.
- PARP inhibition and trapping are key mechanisms for treating BRCA-mutated cancers.
- BRACAnalysis provides comprehensive BRCA germline profiling and has implications for family members.
Conclusions:
- BRACAnalysis is a unique companion diagnostic for ovarian cancer, offering comprehensive genetic insights.
- The availability of BRACAnalysis extends benefits beyond the individual patient to family members.
- The approval signifies an advancement in personalized medicine for ovarian cancer patients with BRCA mutations.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019